Anika Therapeutics, Inc.ANIKNASDAQ
Loading
EPS Diluted Over TimeContracting
Percentile Rank29
Studio
Year-over-Year Change

Diluted earnings per share

Latest
-0.76
↓ 45% vs avg
Percentile
P29
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
-0.52
Historical baseline
PeriodValueYoY Change
TTM-0.76+80.2%
2024-3.83+32.1%
2023-5.64-452.9%
2022-1.02-464.3%
20210.28+116.6%
2020-1.69-189.4%
20191.89+48.8%
20181.27-39.8%
20172.11-1.9%
20162.15-